Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Landcold Gold
- Development stage
- Phase 3
- Lead developer
- Lancet
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Landcold Gold is an oral combination pharmaceutical product developed and marketed by Lancet Pharmaceuticals, a Kolkata-based branded generic company. It is formulated for the symptomatic relief of the common cold, influenza, and allergic rhinitis. The medication typically contains a combination of three active ingredients: paracetamol (acetaminophen), phenylephrine hydrochloride, and chlorpheniramine maleate. Paracetamol serves as an analgesic and antipyretic by inhibiting prostaglandin synthesis in the central nervous system. Phenylephrine acts as a sympathomimetic decongestant by targeting alpha-1 adrenergic receptors to induce vasoconstriction in the nasal passages. Chlorpheniramine maleate is a first-generation H1 receptor antagonist that alleviates allergic symptoms such as sneezing, rhinorrhea, and watery eyes. This combination is a standard therapeutic approach in the Indian generic market for multi-symptom cold relief.
- Brand names
- Landcold Gold
- Other names
- Landcold Gold Tablets
02
Targets
Hb (Hemoglobin)PTGES3PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)NET (Norepinephrine Transporter)SERT (Sodium-dependent serotonin transporter)TRPV1 (Transient receptor potential cation channel subfamily V member 1)ADRA1A (α1A)ADRA1B (α1B)ADRA1D (α1D)HRH1 (Histamine H1 Receptor)DAT (Dopamine plasma membrane transport protein)KCNH2 (Voltage-gated potassium channel subfamily H member 2)
Beyond the preview
Go deeper on Landcold Gold.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Landcold Gold.